Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting

NCT05048589 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12551

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

DRUG: Standard-Dose Quadrivalent Influenza Vaccine
DRUG: High-Dose Quadrivalent Influenza Vaccine

Sponsor

Tor Biering-Sørensen

Collaborators

[object Object]